- Home
- NRXP vs RADX Comparison
NRXP vs RADX Comparison
Compare NRXP & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- RADX
- Stock Information
- Founded
- NRXP 2015
- RADX 2021
- Country
- NRXP United States
- RADX Australia
- Employees
- NRXP N/A
- RADX N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- NRXP Health Care
- RADX
- Exchange
- NRXP Nasdaq
- RADX NYSE
- Market Cap
- NRXP 32.6M
- RADX 32.5M
- IPO Year
- NRXP N/A
- RADX N/A
- Fundamental
- Price
- NRXP $3.39
- RADX $4.02
- Analyst Decision
- NRXP Strong Buy
- RADX Strong Buy
- Analyst Count
- NRXP 4
- RADX 2
- Target Price
- NRXP $28.50
- RADX $13.50
- AVG Volume (30 Days)
- NRXP 284.1K
- RADX 23.1K
- Earning Date
- NRXP 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- NRXP N/A
- RADX N/A
- EPS Growth
- NRXP N/A
- RADX N/A
- EPS
- NRXP N/A
- RADX N/A
- Revenue
- NRXP N/A
- RADX $204,609.00
- Revenue This Year
- NRXP N/A
- RADX N/A
- Revenue Next Year
- NRXP N/A
- RADX N/A
- P/E Ratio
- NRXP N/A
- RADX N/A
- Revenue Growth
- NRXP N/A
- RADX N/A
- 52 Week Low
- NRXP $1.10
- RADX $3.50
- 52 Week High
- NRXP $6.01
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- NRXP 59.13
- RADX N/A
- Support Level
- NRXP $2.90
- RADX N/A
- Resistance Level
- NRXP $3.53
- RADX N/A
- Average True Range (ATR)
- NRXP 0.20
- RADX 0.00
- MACD
- NRXP -0.03
- RADX 0.00
- Stochastic Oscillator
- NRXP 79.37
- RADX 0.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.